A Titrate-to-Goal Study of Switching Patients Uncontrolled on Antihypertensive Monotherapy to Fixed-Dose Combinations of Amlodipine and Olmesartan Medoxomil ± Hydrochlorothiazide
| Autor: | William F. Waverczak, Chunlin Qian, Thomas Littlejohn, Christopher J. Jones, Ali Shojaee, Shawna D. Nesbitt, Willa A. Hsueh, Joel M. Neutel, Matthew R. Weir, Alan Graff |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
medicine.medical_specialty
Ambulatory blood pressure Combination therapy business.industry Endocrinology Diabetes and Metabolism Urology medicine.disease Surgery Hydrochlorothiazide Blood pressure Diabetes mellitus Internal Medicine medicine Amlodipine Cardiology and Cardiovascular Medicine Olmesartan business Adverse effect medicine.drug |
| Zdroj: | The Journal of Clinical Hypertension. 13:404-412 |
| ISSN: | 1524-6175 |
| DOI: | 10.1111/j.1751-7176.2011.00437.x |
| Popis: | In the prospective, open-label, titrate-to-goal Blood Pressure Control in All Subgroups With Hypertension (BP-CRUSH) study, 999 patients with hypertension uncontrolled on monotherapy (mean age, 55.6±11.4 years; baseline blood pressure [BP], 153.7±9.2/91.9±8.6 mm Hg) were switched to fixed-dose amlodipine/olmesartan medoxomil (AML/OM) 5/20 mg. Patients were uptitrated every 4 weeks to AML/OM 5/40 mg and 10/40 mg to achieve BP |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|